Market Cap (In CNY)
5.04 Billion
Revenue (In CNY)
394.4 Million
Net Income (In CNY)
47.33 Million
Avg. Volume
898.73 Thousand
- Currency
- CNY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 17.93-165.21
- PE
- 139.66
- EPS
- 0.58
- Beta Value
- 0.21
- ISIN
- CNE100004C37
- CUSIP
- -
- CIK
- -
- Shares
- 62256986.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Mr. John Li
- Employee Count
- -
- Website
- https://www.hobiotech.com
- Ipo Date
- 2021-01-13
- Details
- HOB Biotech Group Corp.,Ltd. operates as a in vitro diagnostic company in China and internationally. It provides diagnostic tools, such as line immune, enzyme-linked immunosorbent, and chemiluminescent paramagnetic microparticle immuno assays to laboratories and hospitals for the improvement of allergy and autoimmune disease patient care. The company was founded in 2009 and is based in Suzhou, China.
More Stocks
-
RELYRemitly Global, Inc.
RELY
-
SRHGF
-
EQTEQT Corporation
EQT
-
5E2Seatrium Ltd
5E2
-
INST
-
ITCITC Limited
ITC
-
TNABFTenaga Nasional Berhad
TNABF
-
KOSCFKOSÉ Corporation
KOSCF